Lixte Biotechnology Holdings Inc Share Price

NASDAQ: LIXT

Small Cap

$5.69

-0.31

(-5.25%)

as on September 16, 2025 at 1:28 am IST

$₹

Lixte Biotechnology Holdings Inc Stock Performance

as on September 16, 2025 at 1:28 am IST

Day's Low
Day's High
$5.44
Day's Price Range
$6.08
$5.69
4.39%
Downside
6.85%
Upside
52 Week's Low
52 Week's High
$0.64
52-Week Price Range
$6.26
$5.69
88.75%
Downside
10.02%
Upside

Lixte Biotechnology Holdings Inc share price movements today

Previous Close: $6.00
Open: $6.04
Volume: 311.8K
Day's Low - High: $5.44 - $6.08
52 Week Low - High: $0.64 - $6.26

Lixte Biotechnology Holdings Inc Historical Returns

1 Month Return: + 67.27 %
3 Month Return: + 426.75 %
1 Year Return: + 201.76 %
3 Year Return: -14.92 %
5 Year Return: 0 %

Lixte Biotechnology Holdings Inc Stock Fundamentals & Key Indicators

Check Lixte Biotechnology Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$27.4M

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

22684300.00%

Lixte Biotechnology Holdings Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lixte Biotechnology Holdings Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Lixte Biotechnology Holdings Inc	NA	$27.4M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	256.98%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.1B	47.85%	28.07	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.4B	-3.43%	14.11	31.37%

Stock Returns calculator for Lixte Biotechnology Holdings Inc Stock including INR - Dollar returns

The Lixte Biotechnology Holdings Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Lixte Biotechnology Holdings Inc investment value today

Current value as on today

₹2,90,915

Returns

₹1,90,915

(+190.92%)

Returns from Lixte Biotechnology Holdings Inc Stock

₹1,85,930 (+185.93%)

Dollar Returns*

₹4,985 (+4.99%)

Lixte Biotechnology Holdings Inc Stock's Interest Amongst Investors

Search interest for Lixte Biotechnology Holdings Inc Stock has decreased by -3% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 17, 2025 to September 16, 2025

Change:-3% versus previous 30 day period

Lixte Biotechnology Holdings Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-
Operating Income	-1	-1	-1	-1	0	-1	0	0	0	0
EBITDA	0	0	-1	-1	0	-1	0	-1	0	0
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-1	-1	-1	-1	0	-1	0	0	0	0
Income Tax Expense	0	0	0	0	0	-	0	0	-	-
Net Income	-1	-1	-1	-1	0	-1	0	0	0	0
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Lixte Biotechnology Holdings Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	0	-	-	-	-	-	-	-	-	-
Gross Profit	0	-	-	-	-	-	-	-	-	-
Operating Income	-2	-2	-1	-2	-2	-3	-6	-6	-5	-3
EBITDA	-2	-2	-1	-2	-2	-3	0	0	0	-3
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-2	-2	-1	-2	-2	-3	-6	-6	-5	-3
Income Tax Expense	0	0	0	0	0	0	0	0	0	-
Net Income	-2	-2	-1	-2	-2	-3	-6	-6	-5	-3
Net Profit Margin	-1426.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Lixte Biotechnology Holdings Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Jun 2025
Net Income	-1	-1	-1	0	-1	0	0	0
Operating Cash Flow	-1	0	0	0	0	0	0	0
Investing Cash Flow	-	-	3	-	-	-	-	-
Financing Cash Flow	-	3	-	-	-	-	-	0
Change in Cash	-1	2	0	0	0	0	0	0

Lixte Biotechnology Holdings Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-2	-1	-2	-2	-3	-6	-6	-5	-3
Operating Cash Flow	-1	-1	-1	-1	-2	-4	-4	-4	-3
Investing Cash Flow	0	-	-	-	-	-	5	-	-
Financing Cash Flow	1	2	4	4	4	3	5	3	-
Change in Cash	0	1	2	-1	2	0	0	-1	-3

Global Institutional Holdings in Lixte Biotechnology Holdings Inc

Funds	Holdings
FNY Investment Advisers, LLC	3.53%
HighTower Advisors, LLC	3.28%
Ethos Financial Group LLC	0.82%
Citadel Advisors Llc	0.81%
Geode Capital Management, LLC	0.76%

See all

Insights on Lixte Biotechnology Holdings Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, LIXT has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 3 months, LIXT stock has moved up by 426.8%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 138.4%

About Lixte Biotechnology Holdings Inc

lixte biotechnology holdings, inc. (lixte) is a clinical-stage public (lixt) pharmaceutical company dedicated to discovering drugs for more effective treatments for cancer. lixte has identified molecular signaling pathways altered in disease states and designed compounds that can safely target them in animal models. the current drug portfolio includes inhibitors of protein phosphatases that are critical to cell division and dna damage repair and inhibitors of protein deacetylases that regulate pathways of gene expression and protein degradation. the phosphatase inhibitors enhance the effectiveness of cytotoxic anti-cancer drugs in general as well as radiation therapy making them potentially useful for the treatment of many, if not all, cancers in combination with existing standard chemotherapy regimens and the evolving targeted cytotoxic therapies of personalized cancer medicine. the lead compound lb-100 is in phase i trial and has the potential to be first-in-class. the deacetylase in

Organisation	Lixte Biotechnology Holdings Inc
Headquarters	680 East Colorado Boulevard, Pasadena, CA, United States, 91101
Industry	Biotechnology
CEO	Mr. Geordan G. Pursglove
E-voting on shares	Click here to vote

Key Management of Lixte Biotechnology Holdings Inc

Name	Title
Mr. Bastiaan van der Baan M.Sc.	President & Chief Scientific Officer
Mr. Geordan G. Pursglove	CEO & Chairman
Mr. Peter M. Stazzone	Chief Financial Officer

FAQs

What is Lixte Biotechnology Holdings Inc share price today?

Lixte Biotechnology Holdings Inc share price today is $5.69 as on September 16, 2025 at 1:28 am IST at the close of the market. Lixte Biotechnology Holdings Inc share today touched a day high of $6.08 and a low of $5.44.

What is the 52 week high and 52 week low for Lixte Biotechnology Holdings Inc share?

Lixte Biotechnology Holdings Inc share touched a 52 week high of $6.26 on September 12, 2025 and a 52 week low of $0.64 on June 18, 2025. Lixte Biotechnology Holdings Inc stock price today i.e. September 16, 2025 at 1:28 am IST is closed at $5.69,which is 9.11% down from its 52 week high and 789.06% up from its 52 week low.

What is Lixte Biotechnology Holdings Inc's market capitalisation today?

Lixte Biotechnology Holdings Inc market capitalisation is $0.00T as on September 16, 2025 at 1:28 am IST.

How to invest in Lixte Biotechnology Holdings Inc Stock (LIXT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Lixte Biotechnology Holdings Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lixte Biotechnology Holdings Inc Shares that will get you 0.2636 shares as per Lixte Biotechnology Holdings Inc share price of $5.69 per share as on September 16, 2025 at 1:28 am IST.

What is the minimum amount required to buy Lixte Biotechnology Holdings Inc Stock (LIXT) from India?

Indian investors can start investing in Lixte Biotechnology Holdings Inc (LIXT) shares with as little as ₹88.141 or $1 (as of September 16, 2025 at 2:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Lixte Biotechnology Holdings Inc stock (as per the Rupee-Dollar exchange rate as on September 16, 2025 at 2:40 am IST). Based on Lixte Biotechnology Holdings Inc share’s latest price of $5.69 as on September 16, 2025 at 1:28 am IST, you will get 1.7575 shares of Lixte Biotechnology Holdings Inc. Learn more about fractional shares .